Tags

Type your tag names separated by a space and hit enter

Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience.
Bone Marrow Transplant. 2007 Feb; 39(4):217-21.BM

Abstract

In this study, we retrospectively evaluated the efficacy and safety of total body irradiation (TBI) and granulocyte colony-stimulating factor (G-CSF)-combined high-dose cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSCT) in patients with advanced myelodysplastic syndrome (MDS). We evaluated 22 patients with advanced MDS, including refractory anemia with excess blasts (RAEB; n=10), RAEB in transformation (n=2), acute myelogenous leukemia transformed from MDS (n=6) and chronic myelomonocytic leukemia (n=4). The conditioning regimen consisted of 12 Gy of TBI and high-dose cytarabine (3 g/m(2)) every 12 h for 4 days, and the cytarabine was combined with continuous administration of G-CSF. The stem cell sources were bone marrow or peripheral blood stem cells from human leukocyte antigen (HLA)-identical siblings (n=12) and bone marrow from HLA serologically matched unrelated donors (n=10). Three patients experienced disease relapse, two of whom died of disease progression. Of 22 patients, 16 are currently alive and disease-free. The 5-year estimated overall survival, disease-free survival, relapse and non-relapse mortality rates are 76.7, 72.2, 16.6 and 14.1%, respectively. These results suggest that G-CSF-combined high-dose cytarabine could be a promising component of the conditioning regimen of allogeneic HSCT for advanced MDS, providing a low incidence of both relapse and treatment-related mortality.

Authors+Show Affiliations

Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan. tmori@sc.itc.keio.ac.jpNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17220902

Citation

Mori, T, et al. "Total Body Irradiation and Granulocyte Colony-stimulating Factor-combined High-dose Cytarabine as a Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: a Single-institute Experience." Bone Marrow Transplantation, vol. 39, no. 4, 2007, pp. 217-21.
Mori T, Aisa Y, Yokoyama A, et al. Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience. Bone Marrow Transplant. 2007;39(4):217-21.
Mori, T., Aisa, Y., Yokoyama, A., Nakazato, T., Yamazaki, R., Shimizu, T., Mihara, A., Kato, J., Watanabe, R., Takayama, N., Ikeda, Y., & Okamoto, S. (2007). Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience. Bone Marrow Transplantation, 39(4), 217-21.
Mori T, et al. Total Body Irradiation and Granulocyte Colony-stimulating Factor-combined High-dose Cytarabine as a Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: a Single-institute Experience. Bone Marrow Transplant. 2007;39(4):217-21. PubMed PMID: 17220902.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience. AU - Mori,T, AU - Aisa,Y, AU - Yokoyama,A, AU - Nakazato,T, AU - Yamazaki,R, AU - Shimizu,T, AU - Mihara,A, AU - Kato,J, AU - Watanabe,R, AU - Takayama,N, AU - Ikeda,Y, AU - Okamoto,S, Y1 - 2007/01/15/ PY - 2007/1/16/pubmed PY - 2007/3/28/medline PY - 2007/1/16/entrez SP - 217 EP - 21 JF - Bone marrow transplantation JO - Bone Marrow Transplant VL - 39 IS - 4 N2 - In this study, we retrospectively evaluated the efficacy and safety of total body irradiation (TBI) and granulocyte colony-stimulating factor (G-CSF)-combined high-dose cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSCT) in patients with advanced myelodysplastic syndrome (MDS). We evaluated 22 patients with advanced MDS, including refractory anemia with excess blasts (RAEB; n=10), RAEB in transformation (n=2), acute myelogenous leukemia transformed from MDS (n=6) and chronic myelomonocytic leukemia (n=4). The conditioning regimen consisted of 12 Gy of TBI and high-dose cytarabine (3 g/m(2)) every 12 h for 4 days, and the cytarabine was combined with continuous administration of G-CSF. The stem cell sources were bone marrow or peripheral blood stem cells from human leukocyte antigen (HLA)-identical siblings (n=12) and bone marrow from HLA serologically matched unrelated donors (n=10). Three patients experienced disease relapse, two of whom died of disease progression. Of 22 patients, 16 are currently alive and disease-free. The 5-year estimated overall survival, disease-free survival, relapse and non-relapse mortality rates are 76.7, 72.2, 16.6 and 14.1%, respectively. These results suggest that G-CSF-combined high-dose cytarabine could be a promising component of the conditioning regimen of allogeneic HSCT for advanced MDS, providing a low incidence of both relapse and treatment-related mortality. SN - 0268-3369 UR - https://www.unboundmedicine.com/medline/citation/17220902/Total_body_irradiation_and_granulocyte_colony_stimulating_factor_combined_high_dose_cytarabine_as_a_conditioning_regimen_in_allogeneic_hematopoietic_stem_cell_transplantation_for_advanced_myelodysplastic_syndrome:_a_single_institute_experience_ L2 - https://doi.org/10.1038/sj.bmt.1705578 DB - PRIME DP - Unbound Medicine ER -